DESN logo

Dottikon ES Holding AG Stock Price

SWX:DESN Community·CHF 4.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

DESN Share Price Performance

CHF 318.50
81.00 (34.11%)
CHF 318.50
81.00 (34.11%)
Price CHF 318.50

DESN Community Narratives

There are no narratives available yet.

Snowflake Analysis

Solid track record with excellent balance sheet.

0 Risks
2 Rewards

Dottikon ES Holding AG Key Details

CHF 392.7m

Revenue

CHF 139.9m

Cost of Revenue

CHF 252.8m

Gross Profit

CHF 147.2m

Other Expenses

CHF 105.6m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Nov 28, 2025
7.64
64.38%
26.89%
13.1%
View Full Analysis

About DESN

Founded
1913
Employees
793
CEO
Markus Blocher
WebsiteView website
dottikon.com

Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia. The company’s chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine building blocks. It also offers Dottisol, an isosorbide dimethyl ether for application as a solubility enhancer in cosmetic, pharma, and agro products, as well as a performance additive in various industries. In addition, the company is involved in recycling and waste treatment which includes the recycling, thermal recovery, and high-temperature incineration of waste streams, as well as wastewater treatment and purification activities. Further, it offers chemical custom manufacturing, nitrosamine risk assessment, and containment services; and performance chemicals, including aromatic and alicyclic diamines, bio-based organosilanes, and phlegmatized azides. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. Dottikon ES Holding AG is a subsidiary of EVOLMA Holding AG.